✦ LIBER ✦

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)

✍ Scribed by C.M.L. van Herpen; L.D. Locati; J. Buter; J. Thomas; J. Bogaerts; D. Lacombe; P. de Mulder; A. Awada; L. Licitra; J. Bernier; J.B. Vermorken

Book ID: 116429788
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 101 KB
Volume: 44
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2008.08.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of mitoxantrone in locall

Phase II study of mitoxantrone in locally advanced or metastatic adenoid cystic carcinomas (ACC) of the head and neck

✍ Verweij, J.; de Mulder, P.; de Graeff, A.; Wildiers, J.; Vermorken, J.; Cognetti 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Phase II study of rubitecan in recurrent

Phase II study of rubitecan in recurrent or metastatic head and neck cancer

✍ Francesco Caponigro; Giacomo Cartenì; Jean Pierre Droz; Amalia Milano; Wayne B. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 236 KB

Evaluation of Gemcitabine in Patients wi

Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II Study

✍ Wolfram E. Samlowski; Holly Gundacker; J. Philip Kuebler; Jeffrey K. Giguere; Gl 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 68 KB

Phase II study of the antiangiogenesis a

Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Jennifer E. Tseng; Bonnie S. Glisson; Fadlo R. Khuri; Dong M. Shin; Jeffrey N. M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 3 views

Phase II study of paclitaxel, ifosfamide

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Phase II trial of gemcitabine and paclit

Phase II trial of gemcitabine and paclitaxel (GEMTAX) combination in recurrent or advanced squamous cell carcinoma of the head and neck

✍ O. Kucuk; J. Fontana; J. Ensley 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB